The DOI matches its Crossref record; 96 of the 96 references it cites were found in a registry or an index.
Chromone: A Valid Scaffold in Medicinal Chemistry
Open accessAbstract
Chromones are a group of naturally occurring compounds that are ubiquitous in nature, especially in plants. The word chromone is derived from the Greek word chroma, meaning “color”, which point out that many chromone derivatives can exhibit a diversity of colors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Yadav, V. R., Prasad, S., Gupta, S. C., Sung, B., Phatak, S. S., Zhang, S., & Aggarwal, B. B. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.274613 · Cited by 22
RetractedMembrane transporters in drug development
The International Transporter Consortium, Giacomini, K. M., Huang, S.-M., Tweedie, D. J., Benet, L. Z., Brouwer, K. L. R., Chu, X., Dahlin, A., Evers, R., Fischer, V., et al. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3028 · Cited by 3,340
Vlahos, C. J., Matter, W. F., Hui, K. Y., & Brown, R. F. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37680-9 · Cited by 3,240
Adenosine Receptors as Therapeutic Targets
Jacobson, K. A., & Gao, Z.-G. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd1983 · Cited by 1,431
Walker, E. H., Pacold, M. E., Perisic, O., Stephens, L., Hawkins, P. T., Wymann, M. P., & Williams, R. L. (2000) · Molecular Cell · doi:10.1016/s1097-2765(05)00089-4 · Cited by 1,197
Adenosine receptors as drug targets — what are the challenges?
Chen, J.-F., Eltzschig, H. K., & Fredholm, B. B. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd3955 · Cited by 895
Drugging Topoisomerases: Lessons and Challenges
Pommier, Y. (2013) · ACS Chemical Biology · doi:10.1021/cb300648v · Cited by 839
Strategies in the design of antiviral drugs
De Clercq, E. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd703 · Cited by 652
Targeting phosphoinositide 3-kinase—Moving towards therapy
Marone, R., Cmiljanovic, V., Giese, B., & Wymann, M. P. (2008) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2007.10.003 · Cited by 548
Aromatase Inhibitors in the Treatment of Breast Cancer
Brueggemeier, R. W., Hackett, J. C., & Diaz-Cruz, E. S. (2005) · Endocrine Reviews · doi:10.1210/er.2004-0015 · Cited by 484
Kumar, S., & Koh, J. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms13056102 · Cited by 477
Specific inhibitors of poly(ADP-ribose) synthetase and mono(ADP-ribosyl)transferase.
Banasik, M., Komura, H., Shimoyama, M., & Ueda, K. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)45983-2 · Cited by 476
The development of COX2 inhibitors
Flower, R. J. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1034 · Cited by 459
Priorities in Parkinson's disease research
Meissner, W. G., Frasier, M., Gasser, T., Goetz, C. G., Lozano, A., Piccini, P., Obeso, J. A., Rascol, O., Schapira, A., Voon, V., et al. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3430 · Cited by 436
Sirtuins — novel therapeutic targets to treat age-associated diseases
Lavu, S., Boss, O., Elliott, P. J., & Lambert, P. D. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2665 · Cited by 426
Leahy, J. J. J., Golding, B. T., Griffin, R. J., Hardcastle, I. R., Richardson, C., Rigoreau, L., & Smith, G. C. M. (2004) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2004.09.060 · Cited by 411
PI3K/PTEN signaling in tumorigenesis and angiogenesis
Jiang, B.-H., & Liu, L.-Z. (2008) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2007.09.008 · Cited by 345
Flavonoids and their glycosides, including anthocyanins
Veitch, N. C., & Grayer, R. J. (2011) · Natural Product Reports · doi:10.1039/c1np00044f · Cited by 297
Coumarins Derivatives as Dual Inhibitors of Acetylcholinesterase and Monoamine Oxidase
Brühlmann, C., Ooms, F., Carrupt, P.-A., Testa, B., Catto, M., Leonetti, F., Altomare, C., & Carotti, A. (2001) · Journal of Medicinal Chemistry · doi:10.1021/jm010894d · Cited by 290
Fernández-Bachiller, M. I., Pérez, C., Monjas, L., Rademann, J., & Rodríguez-Franco, M. I. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm201460y · Cited by 268
Corradini, E., Foglia, P., Giansanti, P., Gubbiotti, R., Samperi, R., & Laganà, A. (2011) · Natural Product Research · doi:10.1080/14786419.2010.482054 · Cited by 258
CDK inhibitors in cancer therapy: what is next?
Malumbres, M., Pevarello, P., Barbacid, M., & Bischoff, J. R. (2008) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2007.10.012 · Cited by 240
Baraldi, P. G., Tabrizi, M. A., Gessi, S., & Borea, P. A. (2008) · Chemical Reviews · doi:10.1021/cr0682195 · Cited by 238
Understanding the mechanisms of anaphylaxis
Peavy, R. D., & Metcalfe, D. D. (2008) · Current Opinion in Allergy & Clinical Immunology · doi:10.1097/aci.0b013e3283036a90 · Cited by 211
The obesity pipeline: current strategies in the development of anti-obesity drugs
Cooke, D., & Bloom, S. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2136 · Cited by 211
The dual role of thymidine phosphorylase in cancer development and chemotherapy
Bronckaers, A., Gago, F., Balzarini, J., & Liekens, S. (2009) · Medicinal Research Reviews · doi:10.1002/med.20159 · Cited by 206
Studies on antianaphylactic agents—I
Nohara, A., UMETANI, T., & Sanno, Y. (1974) · Tetrahedron · doi:10.1016/s0040-4020(01)97034-6 · Cited by 204
Antiplatelet therapy: in search of the 'magic bullet'
Jackson, S. P., & Schoenwaelder, S. M. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1198 · Cited by 193
Raj, T., Bhatia, R. K., kapur, A., Sharma, M., Saxena, A. K., & Ishar, M. P. S. (2010) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2009.11.001 · Cited by 193
Anaphylaxis: past, present and future
Ben-Shoshan, M., & Clarke, A. E. (2011) · Allergy · doi:10.1111/j.1398-9995.2010.02422.x · Cited by 192
Chromone and Flavonoid Alkaloids: Occurrence and Bioactivity
Khadem, S., & Marles, R. J. (2011) · Molecules · doi:10.3390/molecules17010191 · Cited by 191
The phosphatidyl inositol 3-kinase/AKT signaling pathway in breast cancer
Castaneda, C. A., Cortes-Funes, H., Gomez, H. L., & Ciruelos, E. M. (2010) · Cancer and Metastasis Reviews · doi:10.1007/s10555-010-9261-0 · Cited by 173
Access to Flavones via a Microwave-Assisted, One-Pot Sonogashira−Carbonylation−Annulation Reaction
Awuah, E., & Capretta, A. (2009) · Organic Letters · doi:10.1021/ol901043q · Cited by 171
Semba, S., Itoh, N., Ito, M., Harada, M., & Yamakawa, M. (2002) · PubMed · Cited by 157
Discovery of Chromone‐Based Inhibitors of the Transcription Factor STAT5
Müller, J., Sperl, B., Reindl, W., Kiessling, A., & Berg, T. (2008) · ChemBioChem · doi:10.1002/cbic.200700701 · Cited by 153
Targeted Therapy for Breast Cancer
Mohamed, A., Krajewski, K., Çakar, B., & Ma, C. X. (2013) · American Journal Of Pathology · doi:10.1016/j.ajpath.2013.07.005 · Cited by 152
Fridén‐Saxin, M., Seifert, T., Landergren, M. R., Suuronen, T., Lahtela-Kakkonen, M. K., Jarho, E. M., & Luthman, K. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm3005288 · Cited by 152
Double-edged swords as cancer therapeutics: simultaneously targeting p53 and NF-κB pathways
Dey, A., Tergaonkar, V., & Lane, D. P. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2759 · Cited by 151
Chromone, a Privileged Scaffold for the Development of Monoamine Oxidase Inhibitors
Gaspar, A., Silva, T., Yáñez, M., Viña, D., Orallo, F., Ortuso, F., Uriarte, E., Alcaro, S., & Borges, F. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm2004267 · Cited by 148
Self-citationYang, Q., & Alper, H. (2010) · The Journal of Organic Chemistry · doi:10.1021/jo902210p · Cited by 145
Recanatini, M., Bisi, A., Cavalli, A., Belluti, F., Gobbi, S., Rampa, A., Valenti, P., Palzer, M., Palusczak, A., & Hartmann, R. W. (2001) · Journal of Medicinal Chemistry · doi:10.1021/jm000955s · Cited by 129
Sirtuins in neurodegenerative diseases: an update on potential mechanisms
Min, S., Sohn, P., Cho, S.-H., Swanson, R. A., & Gan, L. (2013) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2013.00053 · Cited by 126
Barve, V., Ahmed, F., Adsule, S., Banerjee, S., Kulkarni, S., Katiyar, P., Anson, C. E., Powell, A. K., Padhyé, S., & Sarkar, F. H. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm051068y · Cited by 123
Ding, J., Vlahos, C. J., Liu, R., Brown, R. F., & Badweyt, J. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.19.11684 · Cited by 123
Targeting DNA repair mechanisms in cancer
Furgason, J. M., & Bahassi, E. M. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.10.009 · Cited by 122
2-(2-Phenylethyl)chromones from Chinese eaglewood
Yang, L., Qiao, L., Xie, D., Yuan, Y., Chen, N., Dai, J., & Guo, S. (2012) · Phytochemistry · doi:10.1016/j.phytochem.2011.11.017 · Cited by 119
Hua, S. (2013) · Frontiers in Pharmacology · doi:10.3389/fphar.2013.00127 · Cited by 113
Target-based selection of flavonoids for neurodegenerative disorders
Jones, Q. R. D., Warford, J. R., Rupasinghe, H. P. V., & Robertson, G. S. (2012) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2012.08.002 · Cited by 113
Respiratory Consequences of Rhinovirus Infection
Greenberg, S. B. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.3.278 · Cited by 112
Hollick, J. J., Golding, B. T., Hardcastle, I. R., Martin, N. M. B., Richardson, C. J., Rigoreau, L. J. M., Smith, G. C. M., & Griffin, R. J. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(03)00652-8 · Cited by 102
Chen, D., Xu, Z., Chai, X., Zeng, K., Jia, Y., Bi, D., Ma, Z., & Tu, P. (2012) · European Journal of Organic Chemistry · doi:10.1002/ejoc.201200725 · Cited by 100
Gilbert, E. R., & Liu, D. (2010) · Current Medicinal Chemistry · doi:10.2174/092986710791111161 · Cited by 100
Matching targets for selective cancer therapy
Blagosklonny, M. V. (2003) · Drug Discovery Today · doi:10.1016/s1359-6446(03)02806-x · Cited by 98
Kim, K. S., Sack, J. S., Tokarski, J. S., Qian, L., Chao, S. T., Leith, L. W., Kelly, Y. F., Misra, R. N., Hunt, J. T., Kimball, S. D., et al. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm000231g · Cited by 94
Valdameri, G., Genoux‐Bastide, E., Pérès, B., Gauthier, C., Guitton, J., Terreux, R., Winnischofer, S. M. B., Rocha, M. E. M., Boumendjel, A., & Pietro, A. D. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm201404w · Cited by 88
Chromone 3-phenylcarboxamides as potent and selective MAO-B inhibitors
Gaspar, A., Reis, J., Fonseca, A., Milhazes, N., Viña, D., Uriarte, E., & Borges, F. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.11.128 · Cited by 85
Self-citationPharmacological modulation of the leukotriene pathway in allergic airway disease
Montuschi, P., Sala, A., Dahlén, S.-E., & Folco, G. C. (2007) · Drug Discovery Today · doi:10.1016/j.drudis.2007.03.004 · Cited by 82
Recent advances in antibacterial drugs
Kaur, M., Rai, J., & Randhawa, G. (2013) · International Journal of Applied and Basic Medical Research · doi:10.4103/2229-516x.112229 · Cited by 81
What makes a good anti-inflammatory drug target?
Simmons, D. L. (2006) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03721-9 · Cited by 80
Vasselin, D. A., Westwell, A. D., Matthews, C. S., Bradshaw, T. D., & Stevens, M. F. G. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm060359j · Cited by 77
Viayna, E., Sabaté, R., & Muñoz‐Torrero, D. (2013) · Current Topics in Medicinal Chemistry · doi:10.2174/15680266113139990139 · Cited by 77
Yang, W. S., Shimada, K., Delva, D., Patel, M., Ode, E., Skouta, R., & Stockwell, B. R. (2011) · ACS Medicinal Chemistry Letters · doi:10.1021/ml200195s · Cited by 76
Selected C7-substituted chromone derivatives as monoamine oxidase inhibitors
Legoabe, L. J., Petzer, A., & Petzer, J. P. (2012) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2012.08.003 · Cited by 60
7-[3-(1-Piperidinyl)propoxy]chromenones as Potential Atypical Antipsychotics
Bolós, J. D., Gubert, S., Anglada, L., Planas, J. M., Burgarolas, C., CASTELLO, J. M., Sacristan, A., & Ortiz, J. A. (1996) · Journal of Medicinal Chemistry · doi:10.1021/jm950894b · Cited by 55
Inhibition of monoamine oxidase by selected C6-substituted chromone derivatives
Legoabe, L. J., Petzer, A., & Petzer, J. P. (2012) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2012.01.037 · Cited by 54
Frazzetto, M., Suphioglu, C., Zhu, J., et al. (2008) · Biochemical Journal · doi:10.1042/bj20080512 · Cited by 52
Selected chromone derivatives as inhibitors of monoamine oxidase
Legoabe, L. J., Petzer, A., & Petzer, J. P. (2012) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2012.07.025 · Cited by 52
Gamal‐Eldeen, A. M., Abdel‐Lateff, A., & Okino, T. (2009) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2009.05.010 · Cited by 51
Boumendjel, A., Nicolle, E., Moraux, T., Gerby, B., Blanc, M., Ronot, X., & Boutonnât, J. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm050705h · Cited by 51
Wu, B., Kwon, S. W., Hwang, G. S., & Park, J. H. (2012) · Helvetica Chimica Acta · doi:10.1002/hlca.201200069 · Cited by 51
Hosseinimehr, S. J., Shafiee, A., Mozdarani, H., Akhlagpour, S., & Froughizadeh, M. (2002) · Journal of Radiation Research · doi:10.1269/jrr.43.293 · Cited by 49
Kumar, S., Singh, B. K., Pandey, A. K., Kumar, A., Sharma, S. K., Raj, H. G., Prasad, A. K., der Eycken, E. V. V., Parmar, V. S., & Ghosh, B. (2007) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2007.02.004 · Cited by 47
Synthesis and Anti-Rhinovirus Properties of Fluoro-Substituted Flavonoids
Conti, C., Mastromarino, P., Goldoni, P., Portalone, G., & Desideri, N. (2005) · Antiviral chemistry & chemotherapy · doi:10.1177/095632020501600406 · Cited by 47
Structural characterization of the cyclin-dependent protein kinase family
Endicott, J., & Noble, M. E. M. (2013) · Biochemical Society Transactions · doi:10.1042/bst20130097 · Cited by 42
Baiz, D., Pinder, T. A., Hassan, S., Karpova, Y., Salsbury, F. R., Welker, M. E., & Kulik, G. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300881a · Cited by 42
Targeting cancer-initiating cell drug-resistance: a roadmap to a new-generation of cancer therapies?
Alama, A., Orengo, A. M., Ferrini, S., & Gangemi, R. M. R. (2011) · Drug Discovery Today · doi:10.1016/j.drudis.2011.02.005 · Cited by 40
Teimouri, M. B., Akbari‐Moghaddam, P., & Golbaghi, G. (2011) · ACS Combinatorial Science · doi:10.1021/co200125a · Cited by 40
Liu, G., Xu, J.-L., Geng, M., Xu, R., Hui, R., Zhao, J., Xu, Q., Xu, H., & Li, J. (2010) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2010.03.020 · Cited by 38
Chromone derivatives which bind to human hair
Walenzyk, T., Carola, C., Buchholz, H. A., & König, B. (2005) · Tetrahedron · doi:10.1016/j.tet.2005.05.081 · Cited by 35
Chromone and chromanone derivatives as strand transfer inhibitors of HIV-1 integrase
Park, J. H., Lee, S. U., Kim, S. H., Shin, S. Y., Lee, J. Y., Shin, C., Yoo, K. H., & Lee, Y. S. (2008) · Archives of Pharmacal Research · doi:10.1007/s12272-008-1111-z · Cited by 35
Insights into the PI3-K-PKB-mTOR signalling pathway from small molecules
Gunn, R. M., & Hailes, H. C. (2008) · Journal of Chemical Biology · doi:10.1007/s12154-008-0008-0 · Cited by 31
The structures of AH15 and AH18, new bi- and tri-phenylethylchromones from agalwood.
Iwagoe, K., Kodama, S., Konishi, T., Kiyosawa, S., Fujiwara, Y., & Shimada, Y. (1987) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.35.4680 · Cited by 27
Kym, P. R., Souers, A. J., Campbell, T. J., Lynch, J. K., Judd, A. S., Iyengar, R., Vasudevan, A., Gao, J., Freeman, J. C., Wódka, D., et al. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm0512286 · Cited by 26
A new chromone glycoside from Rhododendron spinuliferum
Chen, G., Jin, H. Z., Li, X. F., Zhang, Q., Shen, Y. H., Yan, S., & Zhang, W. (2008) · Archives of Pharmacal Research · doi:10.1007/s12272-001-1253-y · Cited by 21
Chromone glycosides and hepatoprotective constituents of Hypericum erectum
An, R. B., Jeong, G. S., Beom, J.-S., Sohn, D. H., & Kim, Y. C. (2009) · Archives of Pharmacal Research · doi:10.1007/s12272-009-2008-1 · Cited by 21
Anti-adipogenic chromone glycosides from Cnidium monnieri fruits in 3T3-L1 cells
Kim, S. B., Ahn, J. H., Han, S., Hwang, B. Y., Kim, S. Y., & Lee, M. K. (2012) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2012.07.103 · Cited by 20
Dopamine Receptor Agonists for Protection and Repair in Parkinsons Disease
Ferrari‐Toninelli, G., Bonini, S. A., Cenini, G., Maccarinelli, G., Grilli, M., Uberti, D. L., & Memo, M. (2008) · Current Topics in Medicinal Chemistry · doi:10.2174/156802608785161402 · Cited by 17
Rationale and Clinical Results of Inhibiting Interleukin-5 for the Treatment of Severe Asthma
Berair, R., & Pavord, I. D. (2013) · Current Allergy and Asthma Reports · doi:10.1007/s11882-013-0379-3 · Cited by 17
Protein kinase inhibitors for the treatment of cancer
Patrick, D. R., & Heimbrook, D. C. (1996) · Drug Discovery Today · doi:10.1016/1359-6446(96)10030-1 · Cited by 17
Drug targets in inflammation and immunomodulation
Buckle, D. R., & Hedgecock, C. J. R. (1997) · Drug Discovery Today · doi:10.1016/s1359-6446(97)01074-x · Cited by 14
Wang, J., Yang, Z., Wang, B., Yi, X.-Y., & Liu, Y. (2009) · Journal of Fluorescence · doi:10.1007/s10895-009-0482-y · Cited by 14
Wang, B., & Yang, Z. (2007) · Journal of Fluorescence · doi:10.1007/s10895-007-0298-6 · Cited by 14
2-Arylmethylaminomethyl-5,6-dihydroxychromone derivatives with selective anti-HCV activity
Park, H., Park, K., & Chong, Y. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.04.055 · Cited by 12
Preparative Separation of a Minor Active Chromone from Aloe vera Leaves by CCC
Cao, X., Dong, Y., Hua, Z., et al. (2005) · Journal of Liquid Chromatography & Related Technologies · doi:10.1081/jlc-200063655 · Cited by 9
Prodrugs Designed to Target Transporters for Oral Drug Delivery
Warren, M. S., & Rautio, J. (2010) · Methods and principles in medicinal chemistry · doi:10.1002/9783527633166.ch6 · Cited by 5
Kirkpatrick, P. J. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2061 · Cited by 2
Cited by
Matsui, J. K., Lang, S. B., Heitz, D. R., & Molander, G. A. (2017) · ACS Catalysis · doi:10.1021/acscatal.7b00094 · Cited by 592
Chromone as a Privileged Scaffold in Drug Discovery: Recent Advances: Miniperspective
Reis, J., Gaspar, A., Milhazes, N., & Borges, F. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b01720 · Cited by 414
Self-citation
Metadata
- Authors
- Gaspar, A., Matos, M. J., Garrido, J., Uriarte, E., & Borges, F.
- Venue
- Chemical Reviews
- Publisher
- American Chemical Society (ACS)
- Published
- 2014-02-21
- Volume
- 114
- Issue
- 9
- Pages
- 4960-4992
- ISSN
- 0009-2665 (ISSN-L)
- 1520-6890
- OpenAlex
- W2038806961
- Cited by
- 760
- References
- 96
- FWCI
- 7.95
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.